Spiramycin
Added to RFQ
For Research & Analytical Purposes. Not for Personal use.
Packaging & Handling
Indicative product packaging is shown for visual reference. Actual packaging may vary based on pack size, quantity, storage condition and shipping requirements.
Documentation Available
Detailed specifications, certificates, and supporting documents are available upon request.
Detailed specifications, certificates, and supporting documents are available upon request.
Storage: Refer MSDS for complete information.
Hazard: Refer MSDS for accurate information.
Spiramycin Product Information
Spiramycin is listed under API and is intended for analytical research, quality control and pharmaceutical reference standard applications. It is associated with Spiramycin. The product is supplied by Clearsynth under CAT No. CS-O-02371.
Clearsynth provides this compound for research and analytical use, with product information including CAS number, molecular formula, molecular weight and product enquiry details.
Technical Data
Product Name
Spiramycin
CAS No.
8025-81-8
CAT No.
CS-O-02371
HSN Code
38229010
Country of Origin
Can be shipped from India, Canada and USA
Molecular Formula
C43H74N2O14
Molecular Weight
843.05
Category
API Family
Storage Condition
Refer MSDS for complete information.
Hazard Compound
Refer MSDS for accurate information.
Description
Regulatory Description
Spiramycin is supplied with detailed characterization data compliant with regulatory guideline. Spiramycin can be used for analytical method development, method validation (AMV), Quality Control (QC) application for Abbreviated New Drug Application (ANDA), or during commercial production of Spiramycin.
Overview
"Spiramycin is a macrolide antibiotic produced by Streptomyces ambofaciens. The drug is effective against gram-positive aerobic pathogens, N. gonorrhoeae, and staphylococci. It is used to treat infections caused by bacteria and Toxoplasma gondii."
Synonyms
Spiramycin
Application Notes
"Spiramycin is a macrolide antibiotic produced by Streptomyces ambofaciens. The drug is effective against gram-positive aerobic pathogens, N. gonorrhoeae, and staphylococci. It is used to treat infections caused by bacteria and Toxoplasma gondii."
Product Applications & Regulatory Search Terms
Useful product, supplier and regulatory search terms for this reference standard.